title: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
abstract: Malignant peritoneal mesothelioma (MPM) is a rare and aggressive neoplasm that is largely resistant to traditional anti-cancer therapies. For years it has been considered a terminal condition and once diagnosed, patients generally survived less than a year despite aggressive treatment. Although rare, the worldwide incidence of MPM continues to rise, in part due to its association with asbestos exposure. Patients usually present with non-specific symptoms of abdominal distension and pain making the diagnosis challenging. In recent years, aggressive cytoreductive surgery with the administration of hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival in patients with MPM treated at multiple centers worldwide. This review article briefly highlights the presentation, diagnosis, and natural history of MPM. We then explore the available treatment options with primary focus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
authors.affiliation: Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27127.
authors.forename: Aaron U
authors.initials: AU
authors.lastname: Blackham
authors.forename: Edward A
authors.initials: EA
authors.lastname: Levine
references.citation: Ann Oncol. 2007 Jun;18(6):985-90
references.pmid: 17030547
references.citation: Occup Environ Med. 2000 Jul;57(7):488-94
references.pmid: 10854503
references.citation: Gastroenterol Clin Biol. 2007 Oct;31(10):784-8
references.pmid: 18166853
references.citation: Arch Pathol Lab Med. 2006 Nov;130(11):1654-61
references.pmid: 17076527
references.citation: Cancer. 1992 Dec 15;70(12):2969-79
references.pmid: 1451080
references.citation: Surg Oncol Clin N Am. 2003 Jul;12(3):689-701
references.pmid: 14567025
references.citation: World J Gastrointest Oncol. 2010 Feb 15;2(2):109-16
references.pmid: 21160929
references.citation: Br J Ind Med. 1960 Oct;17:260-71
references.pmid: 13782506
references.citation: Eur J Surg Oncol. 2006 Aug;32(6):676-81
references.pmid: 16616827
references.citation: Ann Surg Oncol. 2007 Mar;14(3):1105-13
references.pmid: 17206478
references.citation: Ann Surg Oncol. 2006 Mar;13(3):405-12
references.pmid: 16485159
references.citation: J Am Coll Surg. 2007 May;204(5):943-53; discussion 953-5
references.pmid: 17481516
references.citation: Cancer. 2005 Nov 15;104(10):2181-8
references.pmid: 16206294
references.citation: Eur J Surg Oncol. 2005 Feb;31(1):53-8
references.pmid: 15642426
references.citation: J Clin Oncol. 2008 Jul 20;26(21):3567-72
references.pmid: 18640937
references.citation: Ann Surg Oncol. 1997 Apr-May;4(3):215-22
references.pmid: 9142382
references.citation: Ann Surg Oncol. 2010 Jan;17(1):45-53
references.pmid: 19856030
references.citation: Chest. 1988 Jan;93(1):159-62
references.pmid: 3335148
references.citation: Am J Clin Pathol. 2007 Sep;128(3):414-22
references.pmid: 17709315
references.citation: Cancer Chemother Pharmacol. 1993;32(3):204-8
references.pmid: 8500225
references.citation: Cancer. 2005 Feb 15;103(4):839-49
references.pmid: 15637690
references.citation: Hum Pathol. 1977 Jan;8(1):83-94
references.pmid: 844856
references.citation: Am J Med. 1980 Mar;68(3):356-62
references.pmid: 7361805
references.citation: J Natl Cancer Inst. 2003 Jan 1;95(1):38-45
references.pmid: 12509399
references.citation: J Surg Oncol. 2008 Sep 15;98(4):268-72
references.pmid: 18726890
references.citation: Occup Environ Med. 1994 Dec;51(12):804-11
references.pmid: 7849863
references.citation: Lung Cancer. 2005 Jul;49 Suppl 1:S109-11
references.pmid: 15950789
references.citation: Occup Med (Lond). 2005 Mar;55(2):79-87
references.pmid: 15757980
references.citation: N Engl J Med. 2005 Oct 13;353(15):1591-603
references.pmid: 16221782
references.citation: Am J Epidemiol. 2004 Jan 15;159(2):107-12
references.pmid: 14718210
references.citation: N Engl J Med. 2005 Oct 13;353(15):1564-73
references.pmid: 16221779
references.citation: Nat Clin Pract Oncol. 2008 Mar;5(3):136-47
references.pmid: 18227828
references.citation: Arch Pathol Lab Med. 2009 Aug;133(8):1317-31
references.pmid: 19653732
references.citation: Eur J Cancer. 1998 Jan;34(1):148-54
references.pmid: 9624250
references.citation: J Clin Oncol. 2009 Dec 20;27(36):6237-42
references.pmid: 19917862
references.citation: Ann Surg Oncol. 2007 Jan;14(1):41-9
references.pmid: 17039392
references.citation: Cancer. 2011 May 1;117(9):1855-63
references.pmid: 21509762
references.citation: Br J Surg. 2007 Nov;94(11):1408-14
references.pmid: 17631678
references.citation: Int J Cancer. 2003 Oct 20;107(1):94-8
references.pmid: 12925962
references.citation: Ann Oncol. 2007 May;18(5):827-34
references.pmid: 17130182
references.citation: Br J Ind Med. 1988 Mar;45(3):182-7
references.pmid: 3348994
references.citation: Lancet. 2001 Feb 10;357(9254):444-5
references.pmid: 11273069
references.citation: J Clin Oncol. 1988 Jan;6(1):147-53
references.pmid: 3335886
references.citation: J Occup Environ Med. 2003 Apr;45(4):451-5
references.pmid: 12708149
references.citation: Crit Rev Toxicol. 2009;39(7):576-88
references.pmid: 19650718
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):447-53
references.pmid: 16428485
references.citation: Am Surg. 2010 Apr;76(4):400-5
references.pmid: 20420251
references.citation: Cancer Res. 1992 Mar 1;52(5):1252-8
references.pmid: 1737387
references.citation: Ultrastruct Pathol. 2002 Mar-Apr;26(2):55-65
references.pmid: 12036093
references.citation: Ann Oncol. 2006 Nov;17(11):1615-9
references.pmid: 16600983
references.citation: Lung Cancer. 2009 May;64(2):211-8
references.pmid: 19042053
references.citation: Clin Lung Cancer. 2005 Jul;7(1):40-6
references.pmid: 16098243
references.citation: Digestion. 1989;43(4):222-7
references.pmid: 2612745
references.citation: Eur J Surg Oncol. 2010 Oct;36(10):997-1003
references.pmid: 20674253
references.citation: J Clin Oncol. 1983 Jun;1(6):386-91
references.pmid: 6668506
references.citation: Clin Lung Cancer. 2003 Sep;5(2):98-106
references.pmid: 14596692
references.citation: Cancer Causes Control. 2009 Aug;20(6):935-44
references.pmid: 19294523
references.citation: Eur J Surg Oncol. 2006 Nov;32(9):948-53
references.pmid: 16806796
references.citation: Ann Surg Oncol. 2010 Oct;17(10):2720-7
references.pmid: 20422458
references.citation: J Cancer Res Clin Oncol. 1992;118(7):547-50
references.pmid: 1624547
references.citation: Ann Surg Oncol. 2007 Feb;14(2):500-8
references.pmid: 17151789
references.citation: Thorax. 1997 Jun;52(6):507-12
references.pmid: 9227715
references.citation: Ann Surg Oncol. 2009 Feb;16(2):463-72
references.pmid: 19082859
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4560-7
references.pmid: 14673042
references.citation: Chest. 2002 Dec;122(6):2224-9
references.pmid: 12475867
references.citation: Int Surg. 1997 Jul-Sep;82(3):240-3
references.pmid: 9372366
references.citation: Ann Oncol. 2010 Feb;21(2):348-353
references.pmid: 19635740
references.citation: Surg Oncol Clin N Am. 2003 Jul;12(3):673-88
references.pmid: 14567024
references.citation: Int J Cancer. 2005 May 20;115(1):142-7
references.pmid: 15645436
references.citation: Dig Dis Sci. 1988 May;33(5):633-9
references.pmid: 2966056